A preprint of preclinical data for Moderna’s coronavirus vaccine suggests it uses delivery technology that is covered by a patent owned by Arbutus and upheld last week.
Moderna’s Mysterious Coronavirus Vaccine Delivery System
A preprint of preclinical data for Moderna’s coronavirus vaccine suggests it uses delivery technology that is covered by a patent owned by Arbutus and upheld last week.